
Bayard L. Powell, MD
Articles by Bayard L. Powell, MD


Bayard L. Powell, MD, from the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses the treatment of older patients with acute myeloid leukemia (AML).

Bayard L. Powell, MD, the Director-At-Large and a Professor in Hematology & Oncology at the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses the next steps for CPI-613 in hematologic malignancies.

Bayard L. Powell, MD, from the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses a phase I study that explored the first-in-class mitochondrial metabolism inhibitor CPI-613 in patients with advanced hematologic malignancies.
Latest Updated Articles
Dr. Powell Discusses CPI-613 in Hematologic MalignanciesPublished: June 11th 2013 | Updated:
Dr. Powell Discusses the Next Steps for CPI-613Published: July 25th 2013 | Updated:
Dr. Powell on the Treatment of Older Patients With AMLPublished: August 20th 2013 | Updated:
Dr. Powell on CPI-613, Cytarabine, Mitoxantrone Combo for AMLPublished: January 9th 2015 | Updated:

